View in EDS PDF Full Text

O USO DE CONCENTRADOS SANGUÍNEOS PARA PREVENÇÃO E TRATAMENTO DAS ALVEOLITES: UMA REVISÃO BIBLIOGRÁFICA.

Saved in:
Bibliographic Details
Title: O USO DE CONCENTRADOS SANGUÍNEOS PARA PREVENÇÃO E TRATAMENTO DAS ALVEOLITES: UMA REVISÃO BIBLIOGRÁFICA.
Alternate Title: THE USE OF BLOOD CONCENTRATES FOR THE PREVENTION AND TREATMENT OF ALVEOLITIS: A BIBLIOGRAPHIC REVIEW.
Authors: OLIVEIRA, ALEXANDRE DA SILVA1, AGUIAR, EDUARDA CRISTINA CAMPOS2 eduardaaguiarcampos1@gmail.com, LIMA, SARA LIA GONÇALVES DE3 saraliagoncalves@gmail.com, OLIVEIRA, RODRIGO SOUKEF4 rsoukef@terra.com.br
Source: Brazilian Journal of Surgery & Clinical Research. set-nov2025, Vol. 52 Issue 3, p76-80. 5p.
Subjects: PLATELET-rich fibrin, ALVEOLAR osteitis, DENTAL extraction, FIBRINOGEN, WOUND healing, COST benefit analysis, PAIN management, SAFETY
Abstract (English): Alveolitis is a common complication after tooth extractions, especially of third molars, characterized by the disintegration of the blood clot and intense pain. Platelet- Rich Fibrin (PRF), a second-generation autologous blood concentrate that does not require chemical additives, has been indicated for the treatment and prevention of this condition. Objective: This study aimed to analyze the role of PRF in the management of alveolitis, highlighting its benefits in accelerating healing, relieving pain, and preventing this postoperative complication. Methodology: A literature review was conducted by searching for articles in databases such as PubMed, LILACS, SciELO, and Google Scholar. The descriptors used were: "Platelet-Rich Fibrin," "alveolitis," and "blood concentrates." The selected studies addressed the efficacy of PRF in this context. Conclusion: PRF demonstrated effectiveness in reducing the incidence of alveolitis, relieving pain, and accelerating the healing process. Furthermore, it presents a superior safety profile and a favorable cost-benefit ratio compared to other therapies. Therefore, PRF constitutes a promising, safe, and biocompatible therapeutic option for the management of alveolitis. [ABSTRACT FROM AUTHOR]
Abstract (Portuguese): A alveolite é uma complicação frequente após extrações dentárias, especialmente de terceiros molares, caracterizada pela desintegração do coágulo sanguíneo e dor intensa. O Fibrina Rica em Plaquetas (PRF), um concentrado sanguíneo autólogo de segunda geração que dispensa o uso de aditivos químicos, tem sido indicado para o tratamento e a prevenção dessa condição. Objetivo: Este estudo teve como objetivo analisar o papel do PRF no manejo da alveolite, destacando seus benefícios na aceleração da cicatrização, no alívio da dor e na prevenção dessa complicação pós-operatória. Metodologia: Foi realizada uma revisão de literatura com busca de artigos nas bases de dados PubMed, LILACS, SciELO e Google Acadêmico. Os descritores utilizados foram: "Fibrina Rica em Plaquetas", "alveolite" e "concentrados sanguíneos". Os estudos selecionados abordaram a eficácia do PRF nesse contexto. Conclusão: O PRF demonstrou eficácia na redução da incidência de alveolite, no alívio da dor e na aceleração do processo de cicatrização. Além disso, apresenta um perfil de segurança superior e um custobenefício favorável em comparação com outras terapias. Portanto, o PRF constitui uma opção terapêutica promissora, segura e biocompatível para o manejo da alveolite. [ABSTRACT FROM AUTHOR]
Copyright of Brazilian Journal of Surgery & Clinical Research is the property of Master Editora and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
Description
Abstract:Alveolitis is a common complication after tooth extractions, especially of third molars, characterized by the disintegration of the blood clot and intense pain. Platelet- Rich Fibrin (PRF), a second-generation autologous blood concentrate that does not require chemical additives, has been indicated for the treatment and prevention of this condition. Objective: This study aimed to analyze the role of PRF in the management of alveolitis, highlighting its benefits in accelerating healing, relieving pain, and preventing this postoperative complication. Methodology: A literature review was conducted by searching for articles in databases such as PubMed, LILACS, SciELO, and Google Scholar. The descriptors used were: "Platelet-Rich Fibrin," "alveolitis," and "blood concentrates." The selected studies addressed the efficacy of PRF in this context. Conclusion: PRF demonstrated effectiveness in reducing the incidence of alveolitis, relieving pain, and accelerating the healing process. Furthermore, it presents a superior safety profile and a favorable cost-benefit ratio compared to other therapies. Therefore, PRF constitutes a promising, safe, and biocompatible therapeutic option for the management of alveolitis. [ABSTRACT FROM AUTHOR]
ISSN:23174404